Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Serostim for HIV-associated Adipose Redistribution Syndrome (HARS)
NCT00294164Phase 3Completed
- Sponsor
- EMD Serono
- Start
- Mar 2001
- Primary completion
- May 2002
- Modality
- Hormone, rProtein (Recombinant Protein), Biologic
01
Overview
A Phase 3 trial of somatropin in HIV-associated adipose redistribution syndrome (HARS), sponsored by EMD Serono. Started Mar 2001; status: completed.
02
Drugs
somatropin
03
Conditions
HIV-associated adipose redistribution syndrome (HARS)
Beyond the preview
Go deeper on NCT00294164.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00294164.